Search research articles
Contact Us
Filters
Showing results (141-150 of 179) with videos related to
Page
of 18
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 16, 2022
Metastatic Rhabdomyosarcoma: Results of the European <i>Paediatric</i> Soft Tissue Sarcoma Study Group MTS 2008 Study and Pooled Analysis With the Concurrent BERNIE Study
Reineke A Schoot, Julia C Chisholm, Michela Casanova, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 25, 2018
Phase I results of a phase I/II study of weekly nab-paclitaxel in paediatric patients with recurrent/refractory solid tumours: A collaboration with innovative therapies for children with cancer
Lucas Moreno, Michela Casanova, Julia C Chisholm, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|
June 29, 2024
Mechanisms of sensitivity and resistance to CDK4/CDK6 inhibitors in hormone receptor-positive breast cancer treatment
Antonino Glaviano, Seth A Wander, Richard D Baird, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 4, 2016
Implementation of mechanism of action biology-driven early drug development for children with cancer
Andrew D J Pearson, Ralf Herold, Raphaël Rousseau, et al.
Cancer Research
|
January 26, 2022
Immune Infiltrate and Tumor Microenvironment Transcriptional Programs Stratify Pediatric Osteosarcoma into Prognostic Groups at Diagnosis
Antonin Marchais, Maria Eugenia Marques da Costa, Bastien Job, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 15, 2024
Chemo-immunotherapy with dinutuximab beta in patients with relapsed/progressive high-risk neuroblastoma: does chemotherapy backbone matter?
Patricia Raiser, Gudrun Schleiermacher, Marion Gambart, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 5, 2014
A five-gene hedgehog signature developed as a patient preselection tool for hedgehog inhibitor therapy in medulloblastoma
Yaping Shou, Douglas M Robinson, Dereck D Amakye, et al.
The American Journal of Surgical Pathology
|
May 5, 2021
Infantile Rhabdomyosarcomas With VGLL2 Rearrangement Are Not Always an Indolent Disease: A Study of 4 Aggressive Cases With Clinical, Pathologic, Molecular, and Radiologic Findings
Joanna Cyrta, Arnaud Gauthier, Marie Karanian, et al.
Haematologica
|
April 2, 2026
First-year results of the International Leukemia/Lymphoma Target Board for pediatric relapsed and refractory hematological malignancies
Uri Ilan, Judith M Boer, Maaike Luesink, et al.
Leukemia
|
December 30, 2022
High caspase 3 and vulnerability to dual BCL2 family inhibition define ETO2::GLIS2 pediatric leukemia
Zakia Aid, Elie Robert, Cécile K Lopez, et al.
Page
of 18
Search research articles
Search
Showing results (141-150 of 179) with videos related to
Sort By:
Page
of 18
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 16, 2022
Metastatic Rhabdomyosarcoma: Results of the European <i>Paediatric</i> Soft Tissue Sarcoma Study Group MTS 2008 Study and Pooled Analysis With the Concurrent BERNIE Study
Reineke A Schoot, Julia C Chisholm, Michela Casanova, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 25, 2018
Phase I results of a phase I/II study of weekly nab-paclitaxel in paediatric patients with recurrent/refractory solid tumours: A collaboration with innovative therapies for children with cancer
Lucas Moreno, Michela Casanova, Julia C Chisholm, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|
June 29, 2024
Mechanisms of sensitivity and resistance to CDK4/CDK6 inhibitors in hormone receptor-positive breast cancer treatment
Antonino Glaviano, Seth A Wander, Richard D Baird, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 4, 2016
Implementation of mechanism of action biology-driven early drug development for children with cancer
Andrew D J Pearson, Ralf Herold, Raphaël Rousseau, et al.
Cancer Research
|
January 26, 2022
Immune Infiltrate and Tumor Microenvironment Transcriptional Programs Stratify Pediatric Osteosarcoma into Prognostic Groups at Diagnosis
Antonin Marchais, Maria Eugenia Marques da Costa, Bastien Job, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 15, 2024
Chemo-immunotherapy with dinutuximab beta in patients with relapsed/progressive high-risk neuroblastoma: does chemotherapy backbone matter?
Patricia Raiser, Gudrun Schleiermacher, Marion Gambart, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 5, 2014
A five-gene hedgehog signature developed as a patient preselection tool for hedgehog inhibitor therapy in medulloblastoma
Yaping Shou, Douglas M Robinson, Dereck D Amakye, et al.
The American Journal of Surgical Pathology
|
May 5, 2021
Infantile Rhabdomyosarcomas With VGLL2 Rearrangement Are Not Always an Indolent Disease: A Study of 4 Aggressive Cases With Clinical, Pathologic, Molecular, and Radiologic Findings
Joanna Cyrta, Arnaud Gauthier, Marie Karanian, et al.
Haematologica
|
April 2, 2026
First-year results of the International Leukemia/Lymphoma Target Board for pediatric relapsed and refractory hematological malignancies
Uri Ilan, Judith M Boer, Maaike Luesink, et al.
Leukemia
|
December 30, 2022
High caspase 3 and vulnerability to dual BCL2 family inhibition define ETO2::GLIS2 pediatric leukemia
Zakia Aid, Elie Robert, Cécile K Lopez, et al.
Page
of 18